2,3-benzodiazepine anxiolytic (Eliem)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name2,3-benzodiazepine anxiolytic (Eliem)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnxiety DisordersDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEliem Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEliem Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersDepression

Other Information

ATC CodeN/A
Related LinksN/A